---
title: "Nouryon Chemical India Pvt Ltd (CENTAKCHEM) — Share Price, Financials & Analysis"
symbol: "CENTAKCHEM"
company: "Nouryon Chemical India Pvt Ltd"
canonical: "https://tapetide.com/stocks/CENTAKCHEM"
generated_at: "2026-10-13T11:02:33.931Z"
---

# Nouryon Chemical India Pvt Ltd (CENTAKCHEM)

Canonical page: https://tapetide.com/stocks/CENTAKCHEM

## Company

- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No

## Latest Price

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- The company has delivered a poor sales growth of 1.55% over past five years.
- Company has a low return on equity of 8.32% over last 3 years.
- Earnings include an other income of Rs.8.06 Cr.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -21% | -10% | -9% |
| revenue growth | -20% | 3% | 2% |

## Financial Statements

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 51.18 | 48.1 | 50.4 | 64.14 | 68.89 | 55.28 |
| Expenses | 33.06 | 31.35 | 35.26 | 52.26 | 57.31 | 47.94 |
| Operating Profit | 18.12 | 16.75 | 15.14 | 11.88 | 11.58 | 7.34 |
| OPM % | 35.4 | 34.82 | 30.04 | 18.52 | 16.81 | 13.28 |
| Other Income | 4.96 | 5.96 | 5.79 | 6.01 | 7.05 | 8.06 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1.27 | 1.09 | 1.41 | 1.59 | 1.2 | 1.16 |
| Profit before tax | 21.81 | 21.62 | 19.52 | 16.3 | 17.43 | 14.24 |
| Tax % | 33.98 | 33.58 | 34.99 | 35.46 | 33.62 | 36.03 |
| Net Profit | 14.4 | 14.36 | 12.69 | 10.52 | 11.57 | 9.11 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4.9 | 4.9 | 4.9 | 4.9 | 4.9 | 4.9 |
| Reserves | 76.95 | 91.31 | 103.91 | 114.43 | 126 | 135.1 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 23.86 | 29 | 12.97 | 13.64 | 14.28 | 15.32 |
| Total Liabilities | 105.71 | 125.21 | 121.78 | 132.97 | 145.18 | 155.32 |
| Fixed Assets | 6.52 | 5.84 | 6.22 | 6.34 | 6.15 | 6.24 |
| CWIP | 0 | 0.08 | 0.09 | 0.35 | 0 | 1.16 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 99.19 | 119.29 | 115.47 | 126.28 | 139.03 | 147.92 |
| Total Assets | 105.71 | 125.21 | 121.78 | 132.97 | 145.18 | 155.32 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | 8.93 | 1.87 | 1.7 | 8.49 | 6.2 |
| Cash from Investing Activity | — | -15.12 | -0.99 | 6.08 | -3.74 | -13.36 |
| Cash from Financing Activity | — | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | — | -6.19 | 0.88 | 7.78 | 4.75 | -7.16 |
| Free Cash Flow | — | 8.44 | 0.12 | -0.27 | 7.82 | 3.82 |
| CFO/OP | — | 96 | 64 | 60 | 145 | 161 |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 40.94 | 37.49 | 52 | 66.87 | 56 | 55.93 |
| Inventory Days | 116.24 | 135.06 | 207.24 | 113.79 | 94.97 | 118.42 |
| Days Payable | 77.95 | 71.92 | 198.75 | 123.92 | 110.5 | 153.84 |
| Cash Conversion Cycle | 79.22 | 100.62 | 60.49 | 56.73 | 40.47 | 20.5 |
| Working Capital Days | 463.99 | 651.84 | 701.25 | 563.95 | 514.41 | 766.18 |
| ROCE % | — | 24.3 | 18.98 | 14.29 | 13.93 | 10.49 |

## Shareholding Pattern

### annual

| Category | Mar 2017 |
| --- | --- |
| Promoters | 52.72% |
| DIIs | 0.1% |
| Public | 47.18% |
| No. of Shareholders | 6436 |

### Quarterly

| Category | Sep 2016 | Dec 2016 | Mar 2017 |
| --- | --- | --- | --- |
| Promoters | 52.72% | 52.72% | 52.72% |
| DIIs | 0.1% | 0.1% | 0.1% |
| Public | 47.18% | 47.18% | 47.18% |
| No. of Shareholders | 6438 | 6436 | 6436 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 5 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 30.21 | Sell |
| EMA (10) | 29.98 | Sell |
| SMA (20) | 31.49 | Sell |
| EMA (20) | 31.2 | Sell |
| SMA (50) | 34.25 | Sell |
| EMA (50) | 33.84 | Sell |
| SMA (100) | 37.77 | Sell |
| EMA (100) | 36.95 | Sell |
| SMA (200) | 42.15 | Sell |
| EMA (200) | 42.11 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 35.87 | Neutral |
| MACD (12,26,9) | -1.54 | Sell |
| Stochastic (14,3,3) | 16.64 | Buy |
| ADX (14) | 42.03 | Buy |
| Williams %R (14) | -79.73 | Neutral |
| ATR (14) | 2.45 | High Volatility |
| ROC (12) | -9.81 | Sell |
| Stoch RSI (14) | 25.02 | Neutral |
| UO (7,14,28) | 43.44 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2017-05-11 | [Compliance Certificate For The Period Ended 31/03/2017 And Audited Financial Results For The Year Ended On 31/03/2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/5/0b48a7a8-005e-4969-b878-ac6476789915.pdf) |
| 2017-05-02 | [Board Meeting On 9Th May 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/5/e683c55b-0808-4e60-a06c-d3c82f9141df.pdf) |
| 2017-05-02 | [Board Meeting On 9Th May 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/5/8a9e8710-3b63-4ccb-b9d1-70059190068c.pdf) |
| 2017-02-14 | [Standalone Financial Results, Limited Review Report for December 31, 2016](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/2/ACEEE7E8_367F_4D6C_BB3F_08DD9E1B708E_164740.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:02:33.931Z.